Anavex Life Sciences Corp. (AVXL)
5.01
+0.16
(+3.30%)
USD |
NASDAQ |
Jan 16, 16:00
5.00
-0.01
(-0.20%)
After-Hours: 05:31
Anavex Life Sciences EPS Diluted (Quarterly): -0.1144 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Verastem, Inc. | -1.347 |
| Ocugen, Inc. | -0.066 |
| AnaptysBio, Inc. | 0.5208 |
| Replimune Group, Inc. | -0.9041 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.825M |
| Total Expenses (Quarterly) | 9.825M |
| Enterprise Value | 345.06M |
| Earnings Yield | -10.86% |
| Normalized Earnings Yield | -10.86 |